Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 发起方
- 入组人数
- 30
- 试验地点
- 4
研究概览
简要总结
Assured treatment with Risperal CONSTA will provide first-episode patients, who have a greater potential for therapeutic response, with their best opportunity for continued improvement in cognitive function beyond three months of treatment.
详细描述
First episode patients have a greater potential for therapeutic response than multi-episode patients, and many of them also havea great desire to rejoin the workforce. Unfortunately, first episode patients become non-compliant or intermittently compliant with prescribed antipsychotic treatment at least as frequently as multi-episode patients. We believe that assured treatment with Risperal CONTSTA will provide first episode patients wiwth their best opporutnity for continued improvement in cognitive function beyond 3 months of treatment and that improvements in cognitive function will be associated with a greater likelihood of employment, real-world outcomes, such as independent living, as well as measures of brain function.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •male or female between 18-40 years of age
- •meet DSM-IV criteria for first-episode schizophreniform, schizophrenia or schizoaffective disorder
排除标准
- •pregnant & breast-feeding women
- •patients with known sensitivity to oral Risperdal